Seeing Is Believing

Currently out of the existing stock ratings of Salim Syed, 174 are a BUY (80.93%), 41 are a HOLD (19.07%).
Analyst Salim Syed, currently employed at MIZUHO, carries an average stock price target met ratio of 62.63% that have a potential upside of 46.27% achieved within 334 days.
Salim Syed’s has documented 416 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASMB, Assembly Biosciences at 01-Sep-2026.
Analyst best performing recommendations are on UBX (UNITY BIOTECHNOLOGY).
The best stock recommendation documented was for UBX (UNITY BIOTECHNOLOGY) at 8/17/2020. The price target of $40 was fulfilled within 1 day with a profit of $1.5 (3.61%) receiving and performance score of 36.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Oct-2024
$400
$22.65 (6.00%)
$400
Buy Since 09-Jan-2024
$450
$72.65 (19.25%)
$450
Hold Since 10-Jan-2025
$435
$57.65 (15.28%)
$400
9 days ago
(04-Sep-2026)
17/18 (94.44%)
$-2.23 (-0.51%)
245
Buy Since 02-Jan-2025
$457
$79.65 (21.11%)
$427
24 days ago
(20-Aug-2026)
11/12 (91.67%)
$23.27 (5.37%)
148
Buy Since 06-Feb-2023
$460
$82.65 (21.90%)
$400
25 days ago
(19-Aug-2026)
2/3 (66.67%)
$17.64 (3.99%)
255
Which stock is Salim Syed most bullish on?
Which stock is Salim Syed most reserved on?
What Year was the first public recommendation made by Salim Syed?